Prospect News: News for BioMarin Pharmaceutical Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with B > Issuers starting with B, SP only > All stories on BioMarin Pharmaceutical Inc. > Stories on BioMarin Pharmaceutical Inc., SP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

BioMarin Pharmaceutical Inc.

8/22/2024	SP	New Issue: JPMorgan prices $1.43 million return notes linked to basket of 20 stocks
6/28/2023	SP	New Issue: JPMorgan prices $1.58 million return notes linked to basket of 20 stocks
10/13/2022	SP	New Issue: GS Finance sells $1 million digital buffered notes linked to stock basket
4/29/2022	SP	New Issue: GS Finance sells $9.25 million basket-linked notes tied to 77 stocks
8/26/2021	SP	New Issue: GS Finance prices $13.14 million leveraged basket-linked notes on 179 stocks
12/24/2020	SP	New Issue: Barclays prices $10 million fixed-coupon autocallable securities on BioMarin
9/28/2020	SP	New Issue: UBS prices $10 million buffered income autocallables tied to BioMarin
9/2/2020	SP	New Issue: Barclays sells $10 million fixed-coupon autocallable notes tied to BioMarin
5/31/2019	SP	Goldman amends Cusip for notes tied to basket of Russell 3000 stocks
5/9/2019	SP	New Issue: Goldman sells $1 million notes tied to basket of Russell 3000 stocks
3/14/2018	SP	New Issue: Credit Suisse sells $2 million ARES linked to basket of 10 stocks
3/13/2018	SP	New Issue: Credit Suisse sells $2.79 million accelerated return notes on 10 stocks
3/7/2018	SP	Credit Suisse plans 18-month ARES linked to basket of 10 stocks
3/7/2018	SP	Credit Suisse to price 18-month ARES linked to basket of 10 stocks
2/20/2018	SP	New Issue: Credit Suisse sells $95,023 call warrants linked to 20 stocks
2/16/2018	SP	New Issue: Credit Suisse sells $149,992 call warrants linked to 20 stocks
2/16/2018	SP	New Issue: Credit Suisse sells $83,500 call warrants linked to 20 stocks
2/15/2018	SP	New Issue: Credit Suisse sells $149,951 call warrants linked to 20 stocks
2/15/2018	SP	New Issue: Credit Suisse sells $175,000 return notes on basket of 20 stocks
2/8/2018	SP	Credit Suisse to price 54-week call warrants linked to 20 stocks
2/8/2018	SP	Credit Suisse to price return notes linked to basket of 20 stocks
2/5/2018	SP	New Issue: JPMorgan sells $5.81 million return notes linked to basket of 20 stocks
2/5/2018	SP	New Issue: Credit Suisse prices $425,971 call warrants linked to 20 stocks
1/31/2018	SP	Credit Suisse to price return notes linked to basket of 20 stocks
1/24/2018	SP	JPMorgan to price return notes linked to basket of 20 stocks
1/24/2018	SP	Credit Suisse to price 54-week call warrants linked to 20 stocks
9/16/2016	SP	New Issue: HSBC prices $3 million of AMPS linked to basket of 20 common stocks
9/8/2016	SP	HSBC plans 15-month AMPS with cap linked to basket of 20 stocks
3/7/2016	SP	New Issue: Bank of America prices $2.2 million enhanced return notes on 10 stocks
2/29/2016	SP	Bank of America to price enhanced return notes linked to 10 stocks
7/28/2015	SP	New Issue: JPMorgan prices $3.87 million 8.6% airbag autocallables linked to BioMarin
7/22/2015	SP	JPMorgan plans 6.6%-8.6% airbag autocallables linked to BioMarin
6/17/2015	SP	New Issue: UBS prices $178,000 trigger autocallable optimization securities linked to BioMarin Pharmaceutical
6/11/2015	SP	New Issue: JPMorgan prices $3.26 million capped return enhanced notes on S&P 500
6/5/2015	SP	New Issue: Credit Suisse prices $1 million 12.75% autocallable yield notes tied to BioMarin
5/8/2015	SP	New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to BioMarin Pharmaceutical
4/27/2015	SP	New Issue: JPMorgan prices $1 million autocallable reverse exchangeables linked to BioMarin
4/21/2015	SP	New Issue: HSBC prices $3.03 million 7.8% airbag autocallables linked to BioMarin
4/15/2015	SP	HSBC plans 6%-8% airbag autocallables tied to BioMarin Pharmaceutical
4/10/2015	SP	New Issue: UBS prices $154,000 trigger autocallable optimization securities linked to BioMarin Pharmaceutical
2/18/2015	SP	New Issue: RBC prices $1.2 million contingent absolute return autocallables linked to BioMarin
2/11/2015	SP	RBC plans contingent absolute return autocallables linked to BioMarin
1/27/2015	SP	New Issue: UBS prices $375,000 trigger phoenix autocallable optimization securities linked to BioMarin Pharmaceutical
1/21/2015	SP	New Issue: JPMorgan prices $3.13 million trigger phoenix autocallables on BioMarin
1/13/2015	SP	JPMorgan plans to price trigger phoenix autocallable notes linked to BioMarin Pharmaceutical
12/1/2014	SP	New Issue: RBC prices $2.12 million buffered optimization notes tied to health care stocks
9/23/2014	SP	New Issue: UBS prices $1.45 million airbag phoenix autocallable notes linked to BioMarin
9/17/2014	SP	New Issue: UBS prices $200,000 trigger phoenix autocallable optimization securities linked to BioMarin Pharmaceutical
9/17/2014	SP	UBS to price airbag phoenix autocallables linked to BioMarin
8/1/2014	SP	New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to BioMarin Pharmaceutical
7/15/2014	SP	New Issue: JPMorgan prices $2.87 million contingent absolute return autocallables tied to BioMarin
7/9/2014	SP	JPMorgan plans contingent absolute return autocallables tied to BioMarin
6/25/2014	SP	New Issue: UBS prices $238,000 contingent absolute return autocallables linked to BioMarin
6/16/2014	SP	New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to BioMarin Pharmaceutical
6/12/2014	SP	New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to BioMarin Pharmaceutical
6/11/2014	SP	New Issue: UBS sells $2.85 million 9% airbag autocallable notes linked to BioMarin
6/4/2014	SP	UBS to price 7.5%-9.5% airbag autocallables linked to BioMarin
5/30/2014	SP	New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to BioMarin Pharmaceutical
2/13/2014	SP	New Issue: UBS prices $600,000 trigger phoenix autocallable optimization securities linked to BioMarin Pharmaceutical
1/31/2014	SP	New Issue: UBS prices $1.41 million 10.3% airbag autocallables linked to BioMarin
1/27/2014	SP	UBS plans 8.3%-10.3% airbag autocallables on BioMarin Pharmaceutical
10/31/2013	SP	New Issue: RBC prices $987,000 airbag yield optimization autocallables on BioMarin
10/23/2013	SP	RBC plans 6.15%-8.15% airbag yield optimization notes tied to BioMarin

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.